KV Pharmaceutical Co., which was the parent of now-defunct Ethex Corp., will pay $17 million to resolve False Claims Act claims. It was alleged that Ethex failed to advise the Centers for Medicare and Medicaid Services that two unapproved products did not qualify for coverage under federal health-care programs. The federal government says Ethex is alleged to have submitted false quarterly reports to the government related to a pair of drugs, Nitroglycerin ER and Hyoscyamine ER.
Source: Boston Herald
Contact us today for a free legal consultation with an experienced attorney.
Fields marked *may be required for submission.
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.